E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/4/2018 in the Prospect News Preferred Stock Daily.

New Issue: Medical Transcription upsizes 11% series A preferreds to $10.5 million

By Marisa Wong

Morgantown, W.Va., April 4 – Medical Transcription Billing Corp. upsized its offering of additional 11% series A cumulative redeemable perpetual preferred stock to $10.5 million.

The company priced 420,000 shares of the series A preferreds (Nasdaq: MTBCP) at $25 per share, according to a Wednesday press release.

The offering is expected to close on April 6.

The company had announced on March 23 that it would place $10 million of the series A preferreds through a best-efforts offering.

H.C. Wainwright & Co. is the placement agent. Boenning & Scattergood, Inc. is co-placement agent.

The company has previously issued multiple tranches of the series A preferreds, as previously reported.

Dividends are payable on the 15th day of each month. The preferreds become redeemable on Nov. 4, 2020 at par plus accrued dividends, as previously noted.

The preferreds are also redeemable upon a change of control.

Proceeds from the latest preferreds will be used for general corporate purposes and supporting growth initiatives.

Medical Transcription is a Somerset, N.J.-based health care information technology company.

Issuer:Medical Transcription Billing, Corp.
Securities:Series A cumulative redeemable perpetual preferred stock
Amount:$10.5 million, or 420,000 shares (increased from $10 million, or 400,000 shares)
Maturity:Perpetual
Dividend:11%, payable monthly
Price:Par of $25.00
Call option:After Nov. 4, 2020 at par and upon a change of control
Placement agent:H.C. Wainwright & Co.,
Co-placement agent:Boenning & Scattergood, Inc.
Pricing date:March 23
Upsizing:April 4
Settlement date:April 6
Preferred stock symbol:Nasdaq: MTBCP
Preferred stock price:$26.25 at close March 22

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.